Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Takako, Doi"'
Autor:
Hiroki Ueo, Itsushi Minoura, Hiroaki Ueo, Ayako Gamachi, Yuichiro Kai, Yoko Kubota, Takako Doi, Miki Yamaguchi, Toshinari Yamashita, Hitoshi Tsuda, Takuya Moriya, Rin Yamaguchi, Yuji Kozuka, Takeshi Sasaki, Takaaki Masuda, Yasuteru Urano, Masaki Mori, Koshi Mimori
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract Breast-conserving surgery has become the preferred treatment method for breast cancer. Surgical margin assessment is performed during surgery, as it can reduce local recurrence in the preserved breast. Development of reliable and lower-cost
Externí odkaz:
https://doaj.org/article/57841e403e1d428fb43fed7ca65cece2
Autor:
Takako, Doi, Kenichi, Inoue, Misono, Misumi, Kayo, Mizuno, Aika, Kawasaki, Keiko, Unno, Tsubasa, Kitada, Chigusa, Ariizumi, Takeshi, Sasaki
Publikováno v:
Japanese Journal of Radiological Technology. 78:772-778
Autor:
Kenichi Inoue, Aika Kawasaki, Chigusa Ariizumi, Keiko Unno, Tsubasa Kitada, Miki Nagashima, Kayo Mizuno, Misono Misumi, Takeshi Sasaki, Takako Doi
Publikováno v:
Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening). 31:153-156
Autor:
Takako, Doi
Publikováno v:
岡山理科大学紀要. B, 人文・社会科学. 58:91-101
Autor:
Takako Doi, Kenichi Inoue, Misono Misumi, Kayo Mizuno, Aika Kawasaki, Keiko Unno, Tsubasa Kitada, Chigusa Ariizumi
Publikováno v:
Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening). 31:7-12
Autor:
Satoshi Morita, Mari S. Oba, Daisuke Shimizu, Shinya Yamamoto, Sadatoshi Sugae, Kazutaka Narui, Satoshi Hasegawa, Itaru Endo, Mikiko Tanabe, Yasushi Ichikawa, Ayako Kito, Akimitsu Yamada, Takashi Ishikawa, Tomoyuki Morita, Kazuhiro Shimada, Shoko Adachi, Takashi Chishima, Takako Doi
Publikováno v:
Anticancer Research. 41:1671-1676
Background/aim This study aimed to investigate the efficacy of first-line gemcitabine monotherapy for metastatic breast cancer (MBC) and its effect on health-related quality of life (HRQoL) compared with treatment of physician's choice (TPC). Patient
Autor:
Tsubasa Kitada, Chigusa Ariizumi, Kenichi Inoue, Misono Misumi, Keiko Unno, Kayo Mizuno, Takako Doi, Aika Kawasaki
Publikováno v:
Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening). 30:137-143
Autor:
Takako Doi, Takeshi Sasaki, Miki Nagashima, Chizuko Tsutsumi, Aika Kawasaki, Kayo Mizuno, Kenichi Inoue, Chigusa Ariizumi, Misono Misumi, Keiko Unno, Kanako Koshimizu
Publikováno v:
Japanese Journal of Radiological Technology. 77:1165-1172
BACKGROUND In the field of breast screening using mammography, announcing to the examinees whether they are dense or not has not been deprecated in Japan. One of the reasons is a shortage of objectivity estimating their dense breast. Our aim is to bu
Autor:
Daisuke Shimizu, Kazutaka Narui, Masatoshi Mogaki, Akihiko Suto, Tomohiko Ota, Takashi Ishikawa, Naoki Niikura, Yutaka Tokuda, Takeshi Sasaki, Mikiko Tanabe, Akimitsu Yamada, Takashi Chishima, Masaru Kuranami, Yasushi Ichikawa, Yuki Saito, Koichiro Tsugawa, Haruki Ogata, Mari S. Oba, Kumiko Kida, Hitoshi Arioka, Norihiko Sengoku, Shuichi Nawata, Yoshimasa Kosaka, Takako Doi, Itaru Endo, Satoshi Morita, Yasuhiro Suzuki
Publikováno v:
The Breast. 47:1-9
Background It is important to determine whether anthracycline-containing regimens or taxane-containing regimens are more effective in individual patients. The present study compared the efficacy of six cycles of docetaxel and cyclophosphamide (TC6) w
Autor:
Shinya, Yamamoto, Kazutaka, Narui, Takashi, Ishikawa, Shoko, Adachi, Kazuhiro, Shimada, Daisuke, Shimizu, Akimitsu, Yamada, Sadatoshi, Sugae, Mikiko, Tanabe, Mari, Oba, Satoshi, Morita, Takako, Doi, Satoshi, Hasegawa, Tomoyuki, Morita, Ayako, Kito, Takashi, Chishima, Yasushi, Ichikawa, Itaru, Endo
Publikováno v:
Anticancer research. 41(3)
This study aimed to investigate the efficacy of first-line gemcitabine monotherapy for metastatic breast cancer (MBC) and its effect on health-related quality of life (HRQoL) compared with treatment of physician's choice (TPC).We enrolled 96 patients